Skip to content
Back to Guavy Wire
Stocks

Fresenius Medical Care Stock Holds Steady Amid Analyst Cautiousness

Instruments
JPM
Share

Fresenius Medical Care's stock price held steady at around EUR 39.03 on Xetra as of September 13, 2026, despite analysts' cautious views. The dialysis specialist has been trading below its earlier highs, but without a significant price movement.

According to analyst ratings from early September 2026, several institutions have expressed caution about the shares. JPMorgan Chase & Co. rates Fresenius Medical Care stock Underweight, indicating limited upside potential. Jefferies & Company Inc. also has an Underperform rating dated August 7, 2026.

In contrast, DZ Bank issued a Kaufen (Buy) rating on August 6, 2026, while Barclays Capital set the stock at Equal Weight on the same date. However, the balance of ratings still tips towards caution, with more bearish or neutral assessments than positive ones.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc